11/20
04:30 pm
pen
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
Low
Report
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
11/20
01:16 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $235.00 to $250.00. They now have an "overweight" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $235.00 to $250.00. They now have an "overweight" rating on the stock.
11/20
11:12 am
pen
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
11/5
11:04 am
pen
Here's Why Penumbra (PEN) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Penumbra (PEN) is a Strong Momentum Stock [Yahoo! Finance]
11/5
09:00 am
pen
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
Low
Report
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
11/4
12:48 pm
pen
Implied Volatility Surging for Penumbra (PEN) Stock Options [Yahoo! Finance]
Low
Report
Implied Volatility Surging for Penumbra (PEN) Stock Options [Yahoo! Finance]
11/4
11:43 am
pen
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
10/31
09:45 pm
pen
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market [Yahoo! Finance Canada]
Medium
Report
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market [Yahoo! Finance Canada]
10/31
02:35 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $225.00 to $235.00. They now have an "overweight" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $225.00 to $235.00. They now have an "overweight" rating on the stock.
10/31
08:35 am
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Robert W. Baird from $244.00 to $248.00. They now have an "outperform" rating on the stock.
Medium
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Robert W. Baird from $244.00 to $248.00. They now have an "outperform" rating on the stock.
10/30
04:05 pm
pen
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
Medium
Report
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
10/25
08:37 am
pen
Penumbra, Inc. (NYSE: PEN) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/18
10:34 am
pen
Penumbra, Inc. (NYSE: PEN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $225.00 price target on the stock, up previously from $200.00.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $225.00 price target on the stock, up previously from $200.00.
10/16
02:34 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $176.00 to $235.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $176.00 to $235.00. They now have a "buy" rating on the stock.
10/14
01:44 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $224.00 to $234.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $224.00 to $234.00. They now have a "buy" rating on the stock.
10/14
10:35 am
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Truist Financial Co. from $200.00 to $235.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Truist Financial Co. from $200.00 to $235.00. They now have a "buy" rating on the stock.
10/14
09:00 am
pen
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
Medium
Report
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
10/10
09:00 am
pen
Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism
Low
Report
Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism
10/8
03:48 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Royal Bank of Canada from $205.00 to $222.00. They now have an "outperform" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Royal Bank of Canada from $205.00 to $222.00. They now have an "outperform" rating on the stock.
10/2
04:30 pm
pen
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
Low
Report
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
9/17
05:06 pm
pen
Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $238.00 price target on the stock.
Medium
Report
Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $238.00 price target on the stock.
9/16
03:00 am
pen
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
Low
Report
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
9/13
07:24 am
pen
North America Clot Management Devices Market Outlook to 2033 Featuring Boston Scientific, Inari Medical, Medtronic, Penumbra, and Teleflex [Yahoo! Finance]
Medium
Report
North America Clot Management Devices Market Outlook to 2033 Featuring Boston Scientific, Inari Medical, Medtronic, Penumbra, and Teleflex [Yahoo! Finance]
9/11
09:17 am
pen
FLOWPHYSIX ANNOUNCES STRATEGIC PARTNERSHIP WITH 3COMMA FOR INTERNATIONAL DISTRIBUTION OF INNOVATIVE THROMBECTOMY DEVICE [Yahoo! Finance]
Medium
Report
FLOWPHYSIX ANNOUNCES STRATEGIC PARTNERSHIP WITH 3COMMA FOR INTERNATIONAL DISTRIBUTION OF INNOVATIVE THROMBECTOMY DEVICE [Yahoo! Finance]
9/4
05:38 am
pen
Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.